CN103800406A - Compound organic zinc preparation - Google Patents
Compound organic zinc preparation Download PDFInfo
- Publication number
- CN103800406A CN103800406A CN201210439401.8A CN201210439401A CN103800406A CN 103800406 A CN103800406 A CN 103800406A CN 201210439401 A CN201210439401 A CN 201210439401A CN 103800406 A CN103800406 A CN 103800406A
- Authority
- CN
- China
- Prior art keywords
- zinc
- organic zinc
- preparation
- compound recipe
- panacis quinquefolii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Belonging to the field of biological medicines, the invention relates to a compound organic zinc preparation, which is prepared from organic zinc and an American ginseng extract as the main raw materials by a conventional preparation process. The compound organic zinc preparation can alleviate chronic fatigue syndrome.
Description
Technical field
The invention belongs to biomedicine field, what be specifically related to is the compositions of a kind of organic zinc and Radix Panacis Quinquefolii extract.
Background technology
Chronic fatigue syndrome (Chronic fatigue syndrome; CFS) being the disease that confirmed fatigue symptom appears in a kind of health, is a group of occurring under modern efficient fast pace life style take extremely tired (comprising physical fatigue and mental fatigue) for a long time as the general syndrome of main outstanding behaviours.And can be with dizziness, headache, insomnia, forgetful, low grade fever, muscle, arthralgia and multiple neuropsychic symptom, its clinical manifestation is mainly reflected in the fatigue of body cerebral nervous system, cardiovascular system, skeletal musculature function, its basic feature for for a long time extremely tired, can not alleviate after having a rest, physico-chemical examination do not have organic disease.Its cause of disease is still not clear, primary disease is mainly in 20～50 years old, and the dysfunction of the system such as nerve that the spiritual environment factor such as, operating pressure irregular with overworked (comprising mental and physical) for a long time, dietetic life and mental pressure are excessive and stress waiting causes, endocrine, immunity, digestion, circulation, motion is in close relations.
The primary treatment method of chronic fatigue syndrome comprises:
(1) many rests as far as possible: the best suggestion that doctor can provide CFS patient is have a rest as far as possible and reduce pressure.Because CFS is self-limited disease, many people can be in 2 weeks need not any treatment and rehabilitation by autoimmunity.You there is melancholy or dejected situation in Fac, perhaps this looks for psychological counselling consultant to have a talk.
(2) Chinese herbal treatment: can make tea with Radix Arctii, Herba Taraxaci, chrythanthemum, golden seal grass etc., drink every day and contribute to treatment.Can comprehensively or alternately drink these tea, drink 4～6 glasss every day, fatigue alleviating is very effective.
Summary of the invention
Object of the present invention is just to provide a kind of prevention and treatment chronic fatigue syndrome (Chronic fatigue syndrome; CFS) organic zinc and the compositions of Radix Panacis Quinquefolii extract, the fundamentally root of relieving fatigue, promotes antisecosis.
For achieving the above object, the present invention by the following technical solutions: the compositions of a kind of organic zinc and Radix Panacis Quinquefolii extract, the organic zinc that contains pharmaceutical dosage, acceptable carrier on the Radix Panacis Quinquefolii extract of pharmaceutical dosage and pharmaceutics.Described effective ingredient is made up of the weight ratio of following component, organic zinc 5-15 part (in zinc), Radix Panacis Quinquefolii extract 200-500 part.Described organic zinc comprises zinc gluconate, zinc lactate and zinc citrate.Described Radix Panacis Quinquefolii extract total saponin content is no less than 5%.
Pharmaceutical composition of the present invention can with receivable carrier pharmaceutically, for example: filler is as starch, microcrystalline Cellulose etc.; Binding agent is as vitamin derivative, starch etc.; Disintegrating agent, as sodium carboxymethyl cellulose, low-substituted hydroxypropyl cellulose etc., is taken by the mode of the oral administrations such as tablet, capsule, granule, oral liquid or pill.
Compared with prior art, advantage of the present invention is: Chinese Medicine and Clavicular nutrient, can increase curative effect like this.
Below the primary raw material using in the present invention is introduced.
Radix Panacis Quinquefolii: be the root of Araliaceae Radix Panacis Quinquefolii Panax quinquefolium L..Main product is in the U.S., Canada.Also there is cultivation on the ground such as China Beijing, Jilin, Liaoning.Excavate the growth root of 3～6 years autumn, section is raw to be used.Radix Panacis Quinquefolii has Antishock function, can obviously improve hemorrhagic shock rats survival rate; Brain is had to sedation, vital center is had to moderate excitation; Also have anti-hypoxia, resist myocardial ischemia, anti-cardiac muscle oxidation, increase myocardial contraction, arrhythmia, resisting fatigue, anti-stress, convulsion, blood sugar lowering, hemostasis and antidiuretic activity.
Zinc is to maintain one of essential trace element of human life, becomes human body to include zinc amount and is about 2 grams, and as the trace element of needed by human, zinc mainly contains the contribution of human body:
Synthetic plurality of enzymes: the metabolism of body fat, protein and carbohydrate all be unable to do without the special protein of a class---the participation of enzyme.Enzyme has a variety of, and wherein many be unable to do without zinc.As far as is known, zinc is relevant with the activity of nearly 300 kinds of enzymes in human body.Human body, just as an eternal chemical plant, is all carrying out various chemical reactions all the time.If there is no zinc, this chemical plant may will stop production.
Enhancing development: the metabolism of zinc wide participation nucleic acid and protein, therefore also has influence on growth, division and differentiation, the especially DNA replication dna of various cells.The zinc speed that can accelerate cell division, remains in higher level the metabolism of cell, so zinc is very important for the infant in growth and development stage in addition.
Strengthen immunologic function: in trace element, zinc is the most obvious on the impact of immunologic function.Zinc can strengthen the phagocytic activity of macrophage, thus performance bactericidal action.
Promote intelligent development: zinc can promote brain cell development and division, for children ' s intelligence development is laid solid material base.Zinc also plays an important role to maintaining Hippocampus function, and in brain, Hippocampus is the important core group of learning and memory, and in Hippocampus, zinc content is the highest.In addition, zinc also participates in neurosecretion activity, and memory function and respond are strengthened.
The specific embodiment
The preparation of embodiment 1 tablet of the present invention
Prescription
Every day 2～3 times, each 2～4.
The preparation of embodiment 2 capsules of the present invention
Prescription
Every day 2～3 times, each 2～4.
Embodiment 3 effect checkings
Summer workload is large, often goes on business, and almost every day, workload was all more than 10 hours, and usually hurried at night to the late into the night, usually with dizziness, headache, insomnia, the mental symptom such as forgetful.Take continuously capsule in embodiment 2 three months, what above-mentioned symptom was equal takes a turn for the better to significance.
Claims (5)
1. a compound recipe organic zinc preparation, is characterized in that: acceptable carrier on the organic zinc that contains pharmaceutical dosage, the Radix Panacis Quinquefolii extract of pharmaceutical dosage and pharmaceutics.
2. compound recipe organic zinc preparation as claimed in claim 1, described effective ingredient is made up of the weight ratio of following component, and its component proportioning is: organic zinc 5-15 part, Radix Panacis Quinquefolii extract 200-500 part.
3. the compound recipe organic zinc preparation as described in claim 1-2, is characterized in that: described organic zinc comprises zinc gluconate, zinc lactate and zinc citrate, and wherein the dosage of organic zinc is in zinc.
4. the compound recipe organic zinc preparation as described in claim 1-2, is characterized in that: Radix Panacis Quinquefolii extract total saponin content is no less than 5%.
5. the compound recipe organic zinc preparation as described in claim 1-4 is in the purposes for the preparation of in relieve chronic fatigue syndrome.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210439401.8A CN103800406A (en) | 2012-11-07 | 2012-11-07 | Compound organic zinc preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210439401.8A CN103800406A (en) | 2012-11-07 | 2012-11-07 | Compound organic zinc preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103800406A true CN103800406A (en) | 2014-05-21 |
Family
ID=50698101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210439401.8A Pending CN103800406A (en) | 2012-11-07 | 2012-11-07 | Compound organic zinc preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103800406A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107319534A (en) * | 2017-08-02 | 2017-11-07 | 袁青贤 | A kind of health food of antifatigue and beauty treatment and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543877A (en) * | 2003-11-19 | 2004-11-10 | 贲庭复 | American ginseng series beverage |
| US20120024291A1 (en) * | 2000-12-07 | 2012-02-02 | Resmed Limited | Mask brace and mask assembly |
-
2012
- 2012-11-07 CN CN201210439401.8A patent/CN103800406A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120024291A1 (en) * | 2000-12-07 | 2012-02-02 | Resmed Limited | Mask brace and mask assembly |
| CN1543877A (en) * | 2003-11-19 | 2004-11-10 | 贲庭复 | American ginseng series beverage |
Non-Patent Citations (4)
| Title |
|---|
| 张力群: "《吃出建康的药食》", 31 January 2011, article ""吃出建康的药食"，张力群，第250页最后1段-第251页第1段，山西科学技术出版社，2011年1月第1版" * |
| 张小莺: "《功能性食品学》", 31 August 2012, article ""功能性食品学"，张小莺，第152页表5-6，科学出版社，2012年8月第1版" * |
| 胡国华: "《复合食品添加剂》", 30 June 2006, article ""复合食品添加剂"，胡国华，第42页第2段，化学工业出版社，2006年6月第1版" * |
| 董捷: "《蜂蜜蜂王浆加工技术》", 31 July 2007, article ""蜂蜜蜂王浆加工技术"，董捷，第77-79页，金盾出版社， 2007年7月第1版" * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107319534A (en) * | 2017-08-02 | 2017-11-07 | 袁青贤 | A kind of health food of antifatigue and beauty treatment and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101890040B (en) | Composition with anti-fatigue effect and application thereof | |
| CN100563697C (en) | Rhodiola rosea hippophae rhamnoides patch and preparation method thereof | |
| CN102652801A (en) | Chinese herbal medicine tea bag for lowering blood sugar and preventing diabetes mellitus complications | |
| CN1857475A (en) | Composition for preventing and treating cardias and cerebral vascular diseases and its application | |
| CN100374129C (en) | Framberry leaf extract effective part and its composition and uses | |
| CN102813199A (en) | Health-care food for prevention and adjuvant therapy of cancer, three-high disease and immunity strengthening | |
| CN1471845A (en) | Healthy food with glossy and rhizoma as main material and preparing method thereof | |
| CN105168846B (en) | A kind of Orally administered composition with physiological function | |
| CN104644734B (en) | A kind of drug for treating type II diabetes and its complication | |
| CN104026568B (en) | A kind of Halth-care composition | |
| CN103800406A (en) | Compound organic zinc preparation | |
| CN101152196A (en) | Application of notoginsen triterpenes and its monomer in preparing medicament for treating melancholia | |
| CN103816256A (en) | Composition with physiological functions | |
| CN103800547A (en) | Medlar extract added organic zinc preparation | |
| CN1788581A (en) | Preparation method of fat-reducing blood sugar-reducing milk powder containing micro gingko leaf, Gymostamma pentaphyllum, haw and konnjaku powder | |
| CN102846792B (en) | Phlegm-dampness constitution composition, preparation method and applications of composition | |
| CN103800371A (en) | Composition of organic zinc and pilose antler powder | |
| CN103800393A (en) | Composition of organic zinc and ginkgo leaf extract | |
| CN104887759A (en) | Ginseng powder wine and preparation method thereof | |
| CN110496212A (en) | A kind of Chinese medicine composition and preparation method thereof improving wine poison constitution | |
| CN103800398A (en) | Composition of organic zinc and lithocarpus ploystachyus reld extract | |
| CN103800391A (en) | Compound organic zinc preparation | |
| CN103800425A (en) | Composition of organic zinc and astragalus extract | |
| CN102225082A (en) | Medicament for preventing and treating diabetes and complications thereof and preparation method thereof | |
| CN102949424A (en) | Medicinal composition for relieving physical fatigue and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140521 |